Skip To Main Content
Otto Visser on Muck Rack

Otto Visser

As seen in: Nature, Wiley Online Library, BMJ Oncology, Frontiers, The Lancet, RTV Oost, ntvg.nl, European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Otto

Contact Otto, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Availability of Stage Information From Cancer Registries Providing Data to the European Cancer Information System for Six Selected Cancers

|
By Cristina Bosetti, Otto Visser
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data supporting this study's findings are held by European Cancer Registries and were used under a specific data-sharing agreement with the European Commission Joint Research Centre. The anonymized dataset and further information that support the findings of this study are available from the corresponding author upon reasonable request.
Open in Who Shared Issue with article?

Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival?

|
By Nikki van Leeuwen, David van Klaveren, Otto Visser, Danielle van Lammeren-Venema
| BMJ Oncology Verified
The Swedish Acute Leukaemia Registry Group revealed differences in acute myeloid leukaemia (AML) management across regional cancer networks using nationwide, population-based data from Sweden. Their studies showed better overall survival (OS) for patients with AML in regional cancer networks where first-line treatment with intensive therapy was more prevalent.
Open in Who Shared Issue with article?

Ontwikkeling van de kans op kanker in 1990-2019

|
By Ghita C.W.M. Puts, Brendy M.M.E. Wauben-Spaetgens, Trienika T.K. Luth, Anne-Wil Kruijt, Akke Albada, Jaike Praagman, Otto Visser
| ntvg.nl
De kankerincidentie in Nederland is in de periode 1989-2017 verdubbeld van 56.000 tot 112.000 nieuwe diagnoses per jaar, zo was in 2019 in het NTvG te lezen.1 Het naar leeftijd gestandaardiseerde incidentiecijfer steeg van 360 per 100.000 naar 459 per 100.000.
Open in Who Shared Issue with article?
See all 19 licensed articles (21 Total)